Advanced Accelerator Applications (AAA) is a global radiopharmaceutical company specializing in the development and commercialization of molecular nuclear medicines for targeted imaging and therapy, primarily in oncology, neurology, and cardiology. It focuses on precision medicine using innovative radioactive isotopes.